July 26, 2014 2:39 PM ET

Pharmaceuticals

Company Overview of Vitreoretinal Technologies, Inc.

Executive Profile

Barry Kuppermann M.D., Ph.D.

Member of the Scientific Advisory Board, Vitreoretinal Technologies, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships
----

Background

Dr. Barry Kuppermann, M.D., Ph.D. is a Professor of Ophthalmology, University of California Irvine. Dr. Kuppermann serves as Principal Investigator of UCI for several multicenter national trials evaluating new drugs and devices for the treatment of diabetic retinopathy, age-related macular degeneration and the ocular complications of AIDS. Dr. Kuppermann is an Associate Professor and Chief of Retina Service at UCI. He served as Acting Chairman of the Department of Ophthalmology ...

Corporate Headquarters

2 Venture
Irvine, California 92618

United States

Phone: 949-753-1008
Fax: 949-753-0719

Board Members Memberships

There is no Board Members Memberships data available.

Education

PhD
California Institute of Technology
MD
University of Miami

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Vitreoretinal Technologies, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.